Verrica Pharmaceuticals Inc.VRCANASDAQ
LOADING
|||
Switch Symbol:
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | 7.06% |
| Q2 2025 | 309.88% |
| Q1 2025 | 1173.31% |
| Q4 2024 | 87.32% |
| Q3 2024 | -147.81% |
| Q2 2024 | 72.43% |
| Q1 2024 | 114.47% |
| Q4 2023 | -770.24% |
| Q3 2023 | 5926.09% |
| Q2 2023 | 248.39% |
| Q1 2023 | 98.97% |
| Q4 2022 | -137.07% |
| Q3 2022 | 163160.00% |
| Q2 2022 | -103.27% |
| Q1 2022 | 176.50% |
| Q4 2021 | -80.18% |
| Q3 2021 | -18.09% |
| Q2 2021 | -100.78% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |